Public Release: 

Latest research on osteoporosis and bone health at ASBMR 2017 Annual Meeting - Sept. 8-11, Denver

Researchers to present new findings on fracture risk in cancer and HIV patients, obesity and bone health, childhood fractures, and the effect of bisphosphonates and fracture liaison services on reducing risk of death for osteoporosis patients


With declines in testing, diagnosis and treatment of osteoporosis patients at high risk for fracture, there is an ever growing need for important research and data to help address the treatment gap which has led to a major challenge for public health: a large number of preventable fractures due to osteoporosis.

Thousands of bone scientists will come together for the American Society for Bone and Mineral Research (ASBMR) 2017 Annual Meeting, the premier scientific meeting in the world on bone, mineral and musculoskeletal science, to present their latest research and collaborate on new opportunities to increase the testing, diagnosis and treatment options.

WHAT: American Society for Bone and Mineral Research Annual Meeting

WHEN: September 8-11, 2017 (Friday to Monday)

WHERE: Colorado Convention Center, Denver, Colorado USA

RSVP: For more information and to register for press credentials, please contact Amanda Darvill at

On Twitter @ASBMR, #ASBMR2017

Selected Highlights

Obesity and Fracture Risk: Researchers will present data on predicting fractures in obese patients with Type 2 Diabetes and look at how exercise during weight loss affects the bone density of older adults with obesity.

Heart and Bone: Reduce the Rate of Bone Loss and the Risk of Death? Scientists will share data that suggests that bisphosphonates may actually be protective for cardiovascular disease. The latest results will also be shared from studies in postmenopausal women with osteoporosis that shows a reduction in fracture rates when treated with Romosozumab and Denosumab.

Closing the Treatment Gap: Amid growing evidence that physicians are screening fewer patients for osteoporosis and an alarming number of patients choosing not to follow treatment regimens despite multiple fractures and evidence of osteoporosis, this joint session with ASBMR and the International Osteoporosis Foundation (IOF) will include the release of a new strategic roadmap and recommendations from multiple stakeholders to prevent future fractures in people who have already fractured.

Fracture Liaison Services Saving Lives: Researchers will share data that shows a marked decline in death rates among patients who have suffered a fracture and received fracture liaison services.

Your Aging Cells: Ying and Yang: There is mounting evidence that senescent cells can indeed be both beneficial for tissue repair and regeneration, as well as detrimental, where they can drive the development of multiple age-related diseases. Scientists will share data about a suicide gene stopping senescent cells - found for the first time in bone - thus preventing aging.

What's Next in the Treatment of Osteoporosis? The landscape of pharmacotherapies for osteoporosis has also changed profoundly with the emergence of several potent anti-resorptive drugs as well as new anabolic agents. In spite of these major positive developments, how long patients should remain on these therapies and their long-term safety remain a source of conjecture and concern. Scientists will highlight the latest knowledge and new advances on osteoporosis treatment.

Disease and fracture risk: Scientists present findings on how cancer affects fracture risk from a large study of nearly 100,000 cancer patients. Data will also be shared from a study that suggests that HIV causes higher rates of vertebral fractures.

Testosterone Treatment in Older Men: Researchers will present findings on the effects of testosterone treatment on the bones, physical function and vitality in older men as well as who should be targeted for treatment and safety considerations.


For a complete program, please visit Full abstracts are available to all registered media or upon request. For more media information and registration details, please go to or contact Amanda Darvill at

The American Society for Bone and Mineral Research (ASBMR) is the leading professional, scientific and medical society established to bring together clinical and experimental scientists involved in the study of bone, mineral and musculoskeletal research. ASBMR encourages and promotes the study of this expanding field through annual scientific meetings, an official journal (Journal of Bone and Mineral Research®), the Primer on Metabolic Bone Diseases and Disorders of Mineral Metabolism, advocacy and interaction with government agencies and related societies. To learn more about upcoming meetings and publications, please visit

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.